Yüklüyor......
A New Venue of TNF Targeting
The first Food and Drug Administration-(FDA)-approved drugs were small, chemically-manufactured and highly active molecules with possible off-target effects, followed by protein-based medicines such as antibodies. Conventional antibodies bind a specific protein and are becoming increasingly importan...
Kaydedildi:
| Yayımlandı: | Int J Mol Sci |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5983675/ https://ncbi.nlm.nih.gov/pubmed/29751683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19051442 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|